• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早发型帕金森病:一种现代且个性化的治疗方法。

Young Onset Parkinson's Disease: A Modern and Tailored Approach.

机构信息

Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Center of Expertise for Parkinson and Movement Disorders, Nijmegen, The Netherlands.

Department of Rehabilitation, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Center of Expertise for Parkinson and Movement Disorders Nijmegen, The Netherlands.

出版信息

J Parkinsons Dis. 2020;10(s1):S29-S36. doi: 10.3233/JPD-202135.

DOI:10.3233/JPD-202135
PMID:32651336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7592661/
Abstract

In people with young onset Parkinson's disease (YOPD), onset of symptoms is between 21 and 40 years of age. The distinction between YOPD and late-onset Parkinson's disease is supported by genetic differences (a genetic etiology is more common in people with YOPD) and clinical differences (e.g., dystonia and levodopa-induced dyskinesias are more common inYOPD). Moreover, people with YOPD tend to have different family and societal engagements compared to those with late-onset PD. These unique features have implications for clinical management, and call for a tailored multidisplinary approach involving shared-decision making.

摘要

在早发性帕金森病(YOPD)患者中,症状发作的年龄在 21 至 40 岁之间。YOPD 和晚发性帕金森病的区别在于遗传差异(YOPD 患者中遗传病因更为常见)和临床差异(例如,YOPD 患者更常见的是肌张力障碍和左旋多巴诱导的运动障碍)。此外,与晚发性 PD 患者相比,YOPD 患者的家庭和社会参与度往往不同。这些独特的特征对临床管理具有重要意义,并需要采用涉及共同决策的定制多学科方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a0a/7592661/04d7461eda24/jpd-10-jpd202135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a0a/7592661/04d7461eda24/jpd-10-jpd202135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a0a/7592661/04d7461eda24/jpd-10-jpd202135-g001.jpg

相似文献

1
Young Onset Parkinson's Disease: A Modern and Tailored Approach.早发型帕金森病:一种现代且个性化的治疗方法。
J Parkinsons Dis. 2020;10(s1):S29-S36. doi: 10.3233/JPD-202135.
2
Clinical Study of 668 Indian Subjects with Juvenile, Young, and Early Onset Parkinson's Disease.668 例印度青少年、青年和早发性帕金森病患者的临床研究。
Can J Neurol Sci. 2022 Jan;49(1):93-101. doi: 10.1017/cjn.2021.40. Epub 2021 Mar 9.
3
Young-onset Parkinson's disease: Its unique features and their impact on quality of life.早发性帕金森病:其独特特征及其对生活质量的影响。
Parkinsonism Relat Disord. 2019 Aug;65:39-48. doi: 10.1016/j.parkreldis.2019.06.001. Epub 2019 Jun 1.
4
Dopamine transporter imaging (123)I-FP-CIT (DaTSCAN) SPET in differential diagnosis of dopa-responsive dystonia and young-onset Parkinson's disease.多巴胺转运体成像(123)I - FP - CIT(DaTSCAN)单光子发射计算机断层扫描在多巴反应性肌张力障碍和早发性帕金森病鉴别诊断中的应用
Hell J Nucl Med. 2012 May-Aug;15(2):134-8.
5
Quality of sleep in young onset Parkinson's disease: Any difference from older onset Parkinson's disease.早发型帕金森病患者的睡眠质量:与晚发型帕金森病患者有差异吗?
Parkinsonism Relat Disord. 2015 May;21(5):461-4. doi: 10.1016/j.parkreldis.2015.02.007. Epub 2015 Feb 18.
6
Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset?丘脑底核深部脑刺激治疗青年发病帕金森病的疗效:发病年龄的作用?
J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):251-7. doi: 10.1136/jnnp-2011-300470. Epub 2011 Dec 16.
7
Better quality of life and less caregiver strain in young-onset Parkinson's disease: a multicentre retrospective cohort study.早发型帕金森病患者的生活质量更好,照顾者压力更小:一项多中心回顾性队列研究。
J Neurol. 2021 Mar;268(3):1102-1109. doi: 10.1007/s00415-020-10266-y. Epub 2020 Oct 27.
8
A young onset Parkinson's patient: a case study.一名早发性帕金森病患者:病例研究。
J Neurosci Nurs. 2004 Oct;36(5):273-7.
9
Early onset Parkinson's disease: are juvenile- and young-onset different?早发性帕金森病:青少年起病型和青年起病型有区别吗?
Mov Disord. 1994 Sep;9(5):539-44. doi: 10.1002/mds.870090506.
10
Young-onset Parkinson's disease: a clinical review.早发型帕金森病:临床综述
Neurology. 1991 Feb;41(2 ( Pt 1)):168-73. doi: 10.1212/wnl.41.2_part_1.168.

引用本文的文献

1
Deep brain stimulation surgical timing, outcomes, and prognostic factors in patients with Parkinson's disease: A Chinese retrospective multicenter cohort study.帕金森病患者的脑深部电刺激手术时机、结果及预后因素:一项中国回顾性多中心队列研究。
PLoS Med. 2025 Aug 1;22(8):e1004670. doi: 10.1371/journal.pmed.1004670. eCollection 2025 Aug.
2
Pathway Analysis and Genetic Markers in Parkinson's Disease: Insights into Subtype-Specific Mechanisms.帕金森病的通路分析与遗传标记:对亚型特异性机制的见解
Mol Neurobiol. 2025 Jul 2. doi: 10.1007/s12035-025-05182-z.
3
AI-Driven Advances in Parkinson's Disease Neurosurgery: Enhancing Patient Selection, Trial Efficiency, and Therapeutic Outcomes.

本文引用的文献

1
Management of Parkinson's Disease During Pregnancy: Literature Review and Multidisciplinary Input.妊娠期帕金森病的管理:文献综述与多学科建议
Mov Disord Clin Pract. 2020 Apr 9;7(4):419-430. doi: 10.1002/mdc3.12925. eCollection 2020 May.
2
Initiation of pharmacological therapy in Parkinson's disease: when, why, and how.帕金森病药物治疗的起始:何时、为何及如何。
Lancet Neurol. 2020 May;19(5):452-461. doi: 10.1016/S1474-4422(20)30036-3. Epub 2020 Mar 12.
3
Clinical and neuroimaging phenotypes of genetic parkinsonism from infancy to adolescence.
人工智能驱动的帕金森病神经外科进展:优化患者选择、试验效率及治疗效果
Brain Sci. 2025 May 9;15(5):494. doi: 10.3390/brainsci15050494.
4
Associations between cognitive screening performance and motor symptoms in Parkinson's disease:a systematic review and meta-analysis.帕金森病认知筛查表现与运动症状之间的关联:一项系统综述和荟萃分析。
Dement Neuropsychol. 2024 Sep 2;18:e20230102. doi: 10.1590/1980-5764-DN-2023-0102. eCollection 2024.
5
Differentiation in theta and gamma activation in weight-shifting learning between people with parkinson's disease of different anxiety severities.不同焦虑严重程度的帕金森病患者在进行体重转移学习时,θ和γ激活的分化。
Geroscience. 2024 Dec;46(6):6283-6299. doi: 10.1007/s11357-024-01236-7. Epub 2024 Jun 18.
6
Unveiling the invisible: a qualitative interview study on the impact of young onset Parkinson's disease on (ex-partners).揭示无形的影响:一项关于早发性帕金森病对(前伴侣)影响的定性访谈研究。
J Neurol. 2024 Aug;271(8):5312-5325. doi: 10.1007/s00415-024-12474-2. Epub 2024 Jun 11.
7
Iron toxicity, ferroptosis and microbiota in Parkinson's disease: Implications for novel targets.帕金森病中的铁毒性、铁死亡与微生物群:对新靶点的启示
Adv Neurotoxicol. 2024;11:105-132. doi: 10.1016/bs.ant.2024.02.001. Epub 2024 Feb 15.
8
The Prevalence of Parkinson's Disease in Poland: Regional and Sex-Related Differences.波兰帕金森病的流行情况:地区和性别差异。
J Parkinsons Dis. 2024;14(3):521-532. doi: 10.3233/JPD-230291.
9
Adipokines, Vitamin D, and Selected Inflammatory Biomarkers among Parkinson's Disease Patients with and without Dyskinesia: A Preliminary Examination.帕金森病伴或不伴运动障碍患者的脂肪因子、维生素D及特定炎症生物标志物:一项初步检查
Metabolites. 2024 Feb 5;14(2):106. doi: 10.3390/metabo14020106.
10
Age and gender differences in non-motor symptoms in people with Parkinson's disease.帕金森病患者非运动症状的年龄和性别差异。
Front Neurol. 2024 Feb 1;15:1339716. doi: 10.3389/fneur.2024.1339716. eCollection 2024.
从婴儿期到青春期遗传帕金森病的临床和神经影像学表型。
Brain. 2020 Mar 1;143(3):751-770. doi: 10.1093/brain/awz345.
4
The genetic architecture of Parkinson's disease.帕金森病的遗传结构。
Lancet Neurol. 2020 Feb;19(2):170-178. doi: 10.1016/S1474-4422(19)30287-X. Epub 2019 Sep 11.
5
Young-onset Parkinson's disease: Its unique features and their impact on quality of life.早发性帕金森病:其独特特征及其对生活质量的影响。
Parkinsonism Relat Disord. 2019 Aug;65:39-48. doi: 10.1016/j.parkreldis.2019.06.001. Epub 2019 Jun 1.
6
Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease.左旋多巴治疗帕金森病的随机延迟启动试验。
N Engl J Med. 2019 Jan 24;380(4):315-324. doi: 10.1056/NEJMoa1809983.
7
Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review.帕金森病非运动症状治疗的研究进展——基于循证医学的评价
Mov Disord. 2019 Feb;34(2):180-198. doi: 10.1002/mds.27602. Epub 2019 Jan 17.
8
Levodopa-induced dyskinesia in Parkinson disease: A population-based cohort study.左旋多巴诱导的帕金森病运动障碍:基于人群的队列研究。
Neurology. 2018 Dec 11;91(24):e2238-e2243. doi: 10.1212/WNL.0000000000006643. Epub 2018 Nov 7.
9
Genotype-phenotype relations for the Parkinson's disease genes SNCA, LRRK2, VPS35: MDSGene systematic review.帕金森病基因 SNCA、LRRK2、VPS35 的基因型-表型关系:MDSGene 系统评价。
Mov Disord. 2018 Dec;33(12):1857-1870. doi: 10.1002/mds.27527. Epub 2018 Oct 24.
10
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts.左旋多巴诱导的帕金森病运动障碍:当前和不断发展的概念。
Ann Neurol. 2018 Dec;84(6):797-811. doi: 10.1002/ana.25364. Epub 2018 Nov 30.